Page 12 - 《中国药房》2023年4期
P. 12

检查员熟练掌握检查技术,这对远程检查员的专业能力                                 14)[2022-05-25]. https://ecompliance.co.jp/FDA/Remote-
          提出了更高要求。因此,我国药监部门可以制定统一的                                 Interactive-Evaluations-of-Drug-Manufacturing-Establish-
          药品生产远程检查培训方针,各省市药监部门以及相应                                 ments_J.pdf.
          的药品检查派出机构可结合各地药品生产企业的信息                             [ 6 ]  National  Science  Foundation.  Pharmaceutical  remote  au‐
                                                                   dit  process[EB/OL].(2020-04-02)[2022-05-25]. https://
          化水平,从药品生产远程检查的具体要求出发,依照方
                                                                   www.nsf.org/knowledge-library/pharmaceutical-remote-audit-
          针制定专门的药品生产远程检查培训方案,将远程检查
                                                                   process.
          员需要熟悉的检查流程和使用的检查技术等作为远程
                                                              [ 7 ]  EMA. Guidance related to GMP/GDP and PMF distant as‐
          检查培训的重点内容,由药品检查派出机构对远程检查
                                                                   sessments. A GMP/GDP distant assessment guidance:ver‐
          员进行检查流程的理论知识培训以及检查技术和设备
                                                                   sion  1[EB/OL].(2020-10-15)[2022-05-25]. https://www.
          的实践操作培训,并且定期组织远程检查的考核,确保
                                                                   ema.europa.eu/en/documents/scientific-guideline/guidance-
          检查员能够熟练掌握相关操作以保证远程检查顺利进                                  related-gmp/gdp-pmf-distant-assessments_en.pdf.
          行,从而构建起一支既具备基础检查知识又掌握高新技                            [ 8 ]  PMDA. Procedure for remote inspection as a part of com‐
          术的远程检查团队。                                                pliance inspection on drugs and regenerative medical pro-
              综上所述,我国的药品生产远程检查模式相较于国                               ducts[EB/OL].(2020-12-16)[2022-05-25]. https://www.
          外仍处于起步阶段,因此我国应当积极借鉴国外典型国                                 pmda.go.jp/files/000238733.pdf.
          家和地区远程检查的理论和实践经验,从上述4条启示                            [ 9 ]  CHAPMAN J. A state-of-the-art virtual inspection metho-
          着手建立并完善适应我国国情的药品生产远程检查                                   dology  using  mixed  reality  technology  gets  high  marks
          模式。                                                      from  European  medicines  agency  inspector  [EB/OL].
          参考文献                                                    (2020-06-09)[2022-05-25]. https://redica.com/pharma-
                                                                   medical-devices-a-state-of-the-art-virtual-inspection-metho-
          [ 1 ]  闫兆光,白鹤,李玉基,等. 关于健全药品生产检查体系
                                                                   dology-using-mixed-reality-technology-gets-high-marks-
               科学准确定位各类检查重点的思考[J]. 中国食品药品监
               管,2021(7):42-49.                                    from-european-medicines-agency-inspector/.
                                                              [10]  林凡钰,梁佳琪,李宗阳,等. 非现场检查工作挑战及美
          [ 2 ]  MOFID S,BOLISLIS W R,BRADING C,et al. The uti-
                                                                   欧经验借鉴研究[J]. 中国食品药品监管,2021(6):48-57.
               lity  of  remote  inspections  during  the  COVID-19  health
                                                              [11]  浙江省药品监督管理局 . “浙苗链”“黑匣子”正式上线
               emergency and in the postpandemic setting[J]. Clin Ther,
                                                                   [EB/OL].(2021-04-15)[2022-05-25]. http://mpa.zj.gov.
               2021,43(12):2046-2063.
                                                                   cn/art/2021/4/15/art_1228989351_58925155.html.
          [ 3 ]  EMA.  Remote  pharmacovigilance  inspections  of  MAHs
               during  a  crisis  situation:points  to  consider  [EB/OL].  [12]  河南省药品监督管理局.省药监局召开会议强力推进药
                                                                   品生产智慧监管“千里眼工程”[EB/OL].(2021-12-20)
              (2012-12-14)[2022-05-25]. https://www.ema.europa.eu/
                                                                   [2022-05-25].  http://yjj. henan. gov. cn/2021/12-27/23720-
               en/documents/regulatory-procedural-guideline/remote-
                                                                   14.html.
               pharmacovigilance-inspections-mahs-during-crisis-situation-
               points-consider_en.pdf.                        [13]  金华市人民政府.我市创新上线药品智慧检查系统[EB/
                                                                   OL].(2021-08-09)[2022-05-25].  http://www. jinhua. gov.
          [ 4 ]  European  Directorate  for  the  Quality  of  Medicines.
                                                                   cn/art/2021/8/9/art_1229159979_60217130.html.
               EDQM  and  real-time  remote  GMP  inspections  of  API
               manufacturers  during  the  COVID-19  pandemic:innova‐  [14]  霍凤兰.稳步推进药品生产非现场监管信息系统试点建
                                                                   设[J].中国食品药品监管,2011(8):30-31.
               tion  overcoming  adversity  [EB/OL].(2022-03-20)[2022-
                                                              [15]  朱明,常丽梅,符祝,等. 移动互联网技术用于药品注册
               05-25]. https://www.edqm.eu/en/edqm-and-real-time-
               remote-gmp-inspections-of-api-manufacturers-during-the-  现场检查实践与效果[J]. 中国药业,2019,28(22):68-70.
                                                              [16]  王丹,欧阳楠,陈颖. 省级职业化药品检查员队伍构建现
               covid-19-pandemic-innovation-overcoming-adversity.
                                                                   状分析[J]. 中国药业,2021,30(2):11-14.
          [ 5 ]  FDA. Remote interactive evaluations of drug manufactu-
                                                                            (收稿日期:2022-08-09  修回日期:2022-09-20)
               ring  and  bioresearch  monitoring  facilities  during  the
                                                                                                  (编辑:邹丽娟)
               COVID-19  public  health  emergency  [EB/OL].(2021-04-







          · 390 ·    China Pharmacy  2023 Vol. 34  No. 4                               中国药房  2023年第34卷第4期
   7   8   9   10   11   12   13   14   15   16   17